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Neural crest cell
Ednra antagonistNCCs) play an intimate role in craniofacial development. Multiple signaling
cascades participate in patterning cranial NCCs, some of which are regulated by endothelin-A receptor
(Ednra) signaling. Ednra−/− embryos die at birth from severe craniofacial defects resulting from disruption
of neural crest cell patterning and differentiation. These defects include homeotic transformation of lower
jaw structures into upper jaw-like structures, suggesting that some cephalic NCCs alter their “identity” in
the absence of Ednra signaling. To elucidate the temporal necessity for Ednra signaling in vivo, we
undertook two strategies. We ﬁrst used a conditional knockout strategy in which mice containing a
conditionally targeted Ednra allele (Ednraﬂ) were bred with mice from the Hand2-Cre and Wnt1-Cre
transgenic mouse strains, two strains in which Cre expression occurs at different time periods within
cranial NCCs. In our second approach, we used an Ednra-speciﬁc antagonist to treat wild type pregnant
mice between embryonic days E8.0 and E10.0, a time frame encompassing the early migration and
proliferation of cranial NCCs. The combined results suggest that Ednra function is crucial for NCC
development between E8.25 and E9.0, a time period encompassing the arrival of NCCs in the arches and/or
early post-migratory patterning. After this time period, Ednra signaling is dispensable. Interestingly, middle
ear structures are enlarged and malformed in a majority of Ednraﬂ/ﬂ;Wnt1-Cre embryos, instead resembling
structures found in extinct predecessors of mammals. These observations suggest that the advent of Ednra
signaling in cranial NCCs may have been a crucial event in the evolution of the mammalian middle ear
ossicles.
© 2009 Elsevier Inc. All rights reserved.IntroductionCranial neural crest cells (NCCs) are an essential component of the
vertebrate craniofacial skeleton (Chai and Maxson, 2006; Muelemans
and Bronner-Fraser, 2007). These cells originate along the neural fold
of the posterior midbrain and hindbrain and migrate into the
pharyngeal arches, transient structures on the ventral embryo surface
(Couly et al., 1993; Fraser et al., 1990; Le Douarin et al., 1993; Lumsden
et al., 1991). Once there, NCCs differentiate into the bone, cartilage and
connective tissue of the face and neck (Couly et al., 1993, 1996;
Kontges and Lumsden, 1996; Lumsden et al., 1991; Noden, 1983;
Noden, 1988). Most facial structures are derived from the ﬁrst
pharyngeal arch, which is classically subdivided into mandibular
and maxillary prominences.
During pharyngeal arch morphogenesis, signals from surrounding
tissues provide crucial patterning cues to NCCs, initiating signalingClouthier).
es, Texas A&M Health Science
A.
l rights reserved.cascades that eventually lead to the development of the vertebrate
jaw (Chai and Maxson, 2006). In the mouse, development of the
bone, cartilage and connective tissue of the lower jaw is regulated in
part by endothelin-1 (Edn1), which is expressed by the ectoderm,
core paraxial mesoderm and pharyngeal pouch endoderm of the
pharyngeal arches (Clouthier et al., 1998; Maemura et al., 1996;
Yanagisawa et al., 1998a). Edn1 induces signaling from its cognate
receptor, the endothelin-A receptor (Ednra), on NCCs (Clouthier et
al., 1998; Yanagisawa et al., 1998a). This in turn initiates the
expression of a transcription factor cascade (Clouthier et al., 2000;
Ozeki et al., 2004; Ruest et al., 2004). Mice containing a targeted
inactivation of the genes encoding Ednra, Edn1, or endothelin
converting enzyme-1 (Ece1, the enzyme that cleaves Edn1 from an
inactive to active form) are born with both craniofacial and
cardiovascular malformations and die shortly after birth (Clouthier
et al., 1998; Kurihara et al., 1994; Ozeki et al., 2004; Ruest et al.,
2004; Yanagisawa et al., 1998a). These defects, which include the
homeotic transformation of lower jaw structures into upper jaw-like
structures, arise in part from mis-patterning of NCCs due to
expansion of maxillary-like gene expression into the distal mandib-
ular arch and a loss of normal mandibular arch-speciﬁc gene
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to be mediated in part by Dlx5 and Dlx6, two genes whose expression
in the pharyngeal arches are largely dependent on Ednra signaling
and whose combined loss also results in loss of mandibular identity
(Beverdam et al., 2002; Depew et al., 2002). Defects in anterior arch
derivatives and homeotic transformation of anterior arch dermal
bones into more posterior-like bones are also observed in edn1-
mutant zebraﬁsh and in embryos with morpholino mediated partial
reduction in Edn1 levels (Kimmel et al., 2003; Miller and Kimmel,
2001; Miller et al., 2000). In addition, mutations in either the gene
encoding the furin protease that cleaves preproendothelin-1 into big
endothelin or the gene encoding phospholipase C β3, the down-
stream intracellular mediator of endothelin signaling, lead to
anterior arch defects (Walker et al., 2006, 2007). In addition to
zebraﬁsh, blocking Ednra signaling in both chick and rat produces
craniofacial defects (Kempf et al., 1998; Spence et al., 1999). These
changes may in part be due to changes in Mef2c function, though
the exact relationship of Ednra signaling and Mef2c function is not
clear (Miller et al., 2007; Verzi et al., 2007). It thus appears that the
function of Edn1/Ednra signaling in pattering NCCs within the
mandibular pharyngeal arch is conserved among vertebrates. In
contrast, while endothelin signaling is conserved among verte-
brates, it is missing in the more basal organisms (Muelemans and
Bronner-Fraser, 2007).
While Ednra signaling is required for NCC development, its timing
and action are less clear. In the mouse, Ednra expression is ﬁrst
observed on NCCs shortly after they leave the neural folds (Sato et al.
2008) and data not shown). Expression of Edn1 on the arch ectoderm
and endoderm occurs around the same time period. In E9.5 Ednra
mutant chimeric embryos, in which Ednra−/− cells are mixed with
wild type cells (referred to as ETA−/− ↔ +/+), Ednra−/− cells are excluded
from the distal mandibular and second arches (Clouthier et al., 2003),
indicating potential roles for Ednra signaling in NCC migration within
the pharyngeal arches. Further, mouse embryos cultured in the
presence of the Ednra-speciﬁc antagonist BQ-123 between E8.5 to
E9.5 exhibit disrupted gene expression in the mandibular arch at
E10.5 (Fukuhara et al., 2004), suggesting a potential role for Ednra in
migratory and early post-migratory patterning. More recently,
migration of NCCs to the pharyngeal arches of Ednra−/− embryos
has been shown to be grossly normal, supporting a role for Ednra in
initiating pattering events (Abe et al., 2007). Consistent with this is
the ﬁnding that injection of human EDN1 protein into the arches of
edn1 mutant zebraﬁsh after most NCC migration is complete can
rescue the mutant phenotype (Miller et al., 2000). Ednra signaling is,
however, dispensable after these early events, as conditional
inactivation of the Ednra gene after E10.5 in the cells within the
mandibular arch that will eventually form the mandible does not
result in lower jaw defects (Ruest et al., 2005).
While it is often difﬁcult to deﬁne the window of gene function
during development, such information is crucial in elucidating
potential downstream signals and pathways that may be active in a
speciﬁc signaling network. In addition, the timing of gene action can
directly determine the developmental processes in which a gene
product is involved. To investigate the timing of Ednra function and
hence its role in NCC patterning during craniofacial development, we
have taken two approaches. First, we have used a mouse strain
carrying a conditional mutation in the Ednra gene (Kedzierski et al.,
2003), and crossed these mice with two Cre transgenic mouse lines in
which Cre expression in NCCs occurs between E8.25 and E9.5. In a
second approach, we have used an Ednra-speciﬁc antagonist (Padilla
et al., 2006; Sprogar et al., 2007; Wu et al., 2001) to knockdown Ednra
signaling at speciﬁc time periods of NCC development. Our results
indicate that Ednra signaling is required for NCC development in a
very narrow temporal window spanning approximately 18 h. In
addition, detailed analysis of aberrant craniofacial structures observed
following reduction in Ednra signaling in both strains suggest a rolefor Ednra signaling in the evolution of the mammalian hearing
apparatus.
Materials and methods
Mice
Ednraﬂox/ﬂox (Ednraﬂ/ﬂ) mice have been previously described
(Kedzierski et al., 2003). Brieﬂy, loxP sites were introduced by
homologous recombination into the 3′ region of the gene, ﬂanking
the last three exons of the gene. Wnt1-Cre (Danielian et al., 1998) (a
gift from Andrew McMahon through Henry Sucov) and Hand2-Cre
(previously referred to as dHAND-Cre (Ruest et al., 2003) transgenic
mouse strains have been previously described.
Breeding and genotyping
Ednraﬂ/ﬂ mice were ﬁrst bred with Wnt1-Cre and Hand2-Cre
transgenic mice to generate Ednraﬂ/+;Wnt1-Cre and Ednraﬂ/+;Hand2-
Cre animals. Ednraﬂ/+;Wnt1-Cre and Ednraﬂ/+;Hand2-Cre female mice
were then bredwith Ednraﬂ/ﬂmalemice to generate Ednraﬂ/ﬂ;Wnt1-Cre
and Ednraﬂ/ﬂ;Hand2-Cre embryos. Mice and embryos were genotyped
by PCR analysis using genomic DNA prepared from tail biopsies or
amniotic sacs. Ednraﬂ genotyping was performed using the primers 5′-
ACACAACCATGGTGTCGA-3′ and 5′-CGGTTCTTATCCATCTCATC-3′. Reac-
tions were visualized on a 1.5% agarose gel. PCR resulted in two bands
in Ednraﬂ/+ samples (∼420 bp and ∼380 bp), one band in Ednraﬂ/ﬂ
(∼420 bp) and one in Ednra+/+ samples (∼380 bp). Cre genotyping was
performed as previously described (Danielian et al.,1998) using the Cre
primers 5′-GGACATGTTCAGGGATCGCCAGGCG-3′ and 5′-GCATAACC-
AGTGAAACAGCATTGCTG-3′.
Recombination PCR
E8.5 to E10.5 Ednraﬂ/ﬂ;Wnt1-Cre or Ednraﬂ/ﬂ;Hand2-Cre embryos
were collected in PBS and mandibular arches dissected, placed in
Eppendorf tubes and digested with proteinase K. Genomic DNA was
extracted and used for recombination PCR using the primers 5′
ACACAACCATGTTGTCGAGGTCGA 3′ and 5′ GAGAACCTACAACTGGG-
GACACAAACAC 3′. This PCR reaction only ampliﬁes the recombined
Ednra allele, producing a 1.2 kb band (Kedzierski et al., 2003). Reaction
products were visualized on a 1% agarose gel.
Skeleton staining
Skeleton staining was performed as previously described by
McLeod (1980). Brieﬂy, E18.5 embryos were eviscerated and
skinned, taking care not to disrupt structures of the lower jaw.
After ﬁxation in 95% ethanol, embryos were incubated two days in
acetone followed by staining for 3–5 days at 37 °C in 70% ethanol/
5% glacial acetic acid containing 0.015% alcian blue (stock solution
of 0.3% in 70% ethanol) and 0.005% alizarin red (stock solution of
0.1% in 95% ethanol). After staining, embryos were cleared by
successive immersions in 1% potassium hydroxide in 20%, 50% and
80% glycerol. Stained skeletons were stored in 25% glycerol/75%
ethanol. Skeletons were analyzed and photographed using an
Olympus SZX12 stereomicroscope ﬁtted with a DP11 digital
camera.
Histology
For histological analysis, E18.5 embryos were ﬁxed in 10% neutral
buffered formalin. After dehydration in graded ethanols and xylene,
embryos were embedded in parafﬁn and sectioned at 7–9 μm. Sections
were counterstained with hematoxylin and eosin and then mounted
with a coverslip using DPX mounting medium (BDH). Sections were
Fig. 1. Timing of Cre expression and Ednra gene recombination inWnt1-Cre and Hand2-
Cre embryos. A–D. Lateral view of whole mount β-galactosidase (β-gal) staining in E8.5
(A, B) and E9.5 (C, D) R26R;Wnt1-Cre (A, C) and R26R; Hand2-Cre (B, D) embryos. A, B. In
a 8.25–E8.5 R26R;Wnt1-Cre embryo, β-gal-labeled cells are observed between the
midbrain/hindbrain and ﬁrst pharyngeal arch (1; see also inset, A′). In an E8.5 R26R;
Hand2-Cre embryo, β-gal labeled cells are observed in the heart (h) and lateral plate
mesoderm but not arch 1 (see also inset, B′). C, D. At E9.5, labeled cells are observed in
pharyngeal arches 1–3 of a R26R; Wnt1-Cre embryo (C) and arches 1 and 2 of a R26R;
Hand2-Cre embryo (D). E, F. PCR that speciﬁcally detects recombination of the Ednraﬂ
allele was performed on DNA isolated from the rostral (R) and caudal (C) halves of E8.5
Ednraﬂ/ﬂ;Wnt1-Cre and Ednraﬂ/ﬂ;Hand2-Cre embryos bisected along the plane denoted
by the line marked “1” (E) (see Materials andmethods for details). Recombination of the
Ednraﬂ allele correlates with sites of β-gal staining in R26R;Wnt1-Cre and R26R;Hand2-
Cre embryos. Recombination in Ednraﬂ/ﬂ;Wnt1-Cre embryos is observed in the posterior
half (including the ﬁrst arch) when the cut line is moved rostral to the ﬁrst arch (line 2 in
E). a, atrium; lb, limb bud; v, ventricle.
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equipped with a SPOT-RT digital camera.
In situ hybridization
Whole mount in situ hybridization analysis was performed as
previously described using digoxigenin (DIG)-labeled antisense cRNA
riboprobes against Hand1, Hand2, Dlx3, Dlx5 and Dlx6 (Ruest et al.,
2003). Embryos were photographed as described above.
Malleus measurement
Mallei were dissected and photographed using a Nikon SMZ1500
microscope ﬁtted with a Nikon DXM1200 digital camera. Captured
images were measured using calibrated digital calipers included with
Metamorph Imaging software (Universal Imaging Corporation). The
length of each malleus was measured from the top of the malleus to
the midpoint between the anterior process and manubrium. Malleus
width was measured across the malleus at a level just below the point
of fusion with Meckel's cartilage.
Antagonist treatment
Wild type 129S6 female mice were mated with 129S6 males, with
noon of the date that the copulatory plug was found counted as E0.5.
Plugged females were weighed daily to assess weight gain before and
after antagonist or control treatment. At noon, midnight or both of the
designated day of treatment (E8.0 to E10.5), females were given either
100 μl water (as a control) or 100 mg/kg body weight TBC3214 in
100 μl water by gavage. TBC3214 is an Ednra-speciﬁc non-peptidic
antagonist that has good oral bioavailability (approximately 25% in
rats), high potency (IC(50)=40 pM), and high Ednra/Ednrb selectivity
(400,000-fold) (Wu et al., 2001). In addition, the half-life is relatively
short (t(1/2)=N4 h; (Wu et al., 2001)) and is well tolerated bymice, with
no obvious signs of toxic affects in treated females (data not shown).
This included normal weight gain after treatment compared with
water-treated females (data now shown). Further, the rate of embryo
resorption and average embryo weight was similar between antago-
nist-treated and water-treated females (Supplementary Fig. 1).
Embryos from water- and TBC3214-treated females were collected
at either E10.5 (whole mount in situ hybridization) or E18.5 (skeleton
staining) and processed as described above.
Data analysis for antagonist study
A minimum of 3 litters (average of 4.7 litters) and a minimum of 20
embryos (average of 35.3 embryos)were analyzed for skeletal defects for
each treatmentmodalitywith the antagonist. Embryoswere individually
scored for structural defect of each analyzed structure and data compiled
as a percentage of embryos having a given structural malformation per
litter. These percentages were then averaged for each structure and
treatment modality, and standard deviation calculated.
Results
Differential timing of Ednra recombination in Ednraﬂ/ﬂ;Wnt1-Cre and
Ednraﬂ/ﬂ;Hand2-Cre embryos
To examine the timing of Ednra signaling during cephalic NCC
development, we took advantage of a conditional mutant mouse
strain in which loxP sites flank the last three exons of the Ednra gene
(we use the abbreviation “ﬂ”) (Kedzierski et al., 2003). This conditional
allele was inactivated using two speciﬁc Cre transgenic mouse strains
inwhich Cre expression occurs at different time points within cephalic
NCCs: Wnt1-Cre (Chai et al., 2000; Danielian et al., 1998) and Hand2-
Cre (Ruest et al., 2003). To compare the early expression of Cre in thesetwo strains, each was bred into the Cre reporter strain R26R (Soriano,
1999). In E8.5 R26R;Wnt1-Cre embryos, β-galactosidase (β-gal)
staining was observed in NCCs migrating towards and in the ﬁrst
arch by E8.5 (Fig. 1A), with the ﬁrst and second arches extensively
labeled by E9.5 (Fig. 1C). In contrast, β-gal staining in E8.5 R26R;
Hand2-Cre embryos was conﬁned to the heart and a portion of the
lateral plate mesoderm (Fig. 1B), with staining in the pharyngeal
arches not observed until E9.5 (Fig. 1D).
We next crossed these strains into the Ednraﬂ background to
inactivate the conditional Ednra allele. To ﬁrst determine if the timing
of Ednra gene recombination in the ﬁrst arch of E8.5 Ednraﬂ/ﬂ;Wnt1-
Cre and Ednraﬂ/ﬂ;Hand2-Cre embryos correlated with β-gal staining in
R26R;Wnt1-Cre and R26R;Hand2-Cre embryos shown above, embryos
Fig. 2. Recombination of the Ednra conditional allele in the mandibular arch of E9.5 and E10.5 Ednraﬂ/ﬂ;Wnt1-Cre and Ednraﬂ/ﬂ;Hand2-Cre embryos. A, B. Agarose gels showing PCR-
generated bands corresponding to presence of a Cre transgene (Cre), Ednraﬂ (ﬂox) or Ednrawild type alleles and a recombined Ednraﬂ allele. DNA was isolated from the mandibular
arch of E9.5 and E10.5 Ednraﬂ/+;Wnt1-Cre, Ednraﬂ/ﬂ;Wnt1-Cre, Ednraﬂ/+;Hand2-Cre and Ednraﬂ/ﬂ;Hand2-Cre embryos. Tail DNA from an adult Ednra+/+;Wnt1-Cre mouse and yolk sac
DNA from E10.5 Ednraﬂ/ﬂ;Wnt1-Cre and Ednraﬂ/ﬂ; Hand2-Cre embryos were used as negative controls. Recombination of the Ednraﬂ allele is only observed in the presence of the Cre
transgene. The presence of the ﬂox band in all samples reﬂects the presence of cells in which the Wnt1-Cre or Hand2-Cre transgenes are not expressed. C–E. In situ hybridization
analysis of conditional inactivation of the Ednra allele using a DIG-labeled probe that only detects the recombined allele. In E10.5 control embryos, Ednra expression can be seen
throughout the mandibular (1) and second (2) arches, with highest expression in the distocaudal aspects (C). In Ednraﬂ/ﬂ;Wnt1-Cre embryos, recombination of the conditional Ednra
allele appears to have occurred throughout the pharyngeal arches (D). In Ednraﬂ/ﬂ;Hand2-Cre embryos, conditional Ednra recombination is only observed in the distal half of the
mandibular and second arches, corresponding to the area of Hand2 expression.
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Fig. 3. Gross analysis of E18.5 Ednraﬂ/ﬂ;Cre embryos. Lateral (A, D, G, J, M) and frontal (B, E, H, K, N) views and sagittal sections (C, F, I, L, O) through the head of wild type (A–C), Ednra−/−
(D–F), Ednraﬂ/ﬂ;Wnt1-Cre (G–L) and Ednraﬂ/ﬂ;Hand2-Cre (M–O) embryos. Sagittal sections were stained with hematoxylin and eosin. Defects in Ednraﬂ/ﬂ;Wnt1-Cre embryo are almost
identical to those observed in Ednra−/− embryos, including a midline cleft in the lower jaw in addition to the presence of mystacial vibrissae (yellow arrows), normally only observed
on the snout. Red arrows (F, I, L) point to the rugae present on the oral surface of the lower jaw, resembling rugae present on the roof of the oral cavity. Some Ednraﬂ/ﬂ;Wnt1-Cre
embryos have a more severe phenotype (J–L), characterized by an absence of tissue in the distal lower jaw (black arrow). No defects are observed in Ednraﬂ/ﬂ;Hand2-Cre embryo
(M–O). i, incisor; md, mandible; t, tongue.
Fig. 4. Skeletal analysis of E18.5 Ednra conditional knockout embryos. Lateral (B, E. H, K, N) and ventral (C, D, F, G, I, J, L, M, O, P) views of the skull and mandible of Ednraﬂ/ﬂ (wild type)
(B–D), Ednra−/− (E–G), Ednraﬂ/ﬂ;Wnt1-Cre (H–M), Ednraﬂ/ﬂ;Hand2-Cre (N–P) embryos. A. A schematic drawing showing the bones of the mouse skull (abbreviations given below). B–D.
Skull and mandible (md) structure of a Ednraﬂ/ﬂ (wild type) embryo. E–G. In Ednra−/− embryos, the mandible is ﬂattened and resembles a maxilla (referred to as a pseudo-maxilla
(mx⁎)) (E, F), though overall size is smaller. Duplications of the jugal bones (j⁎) and palatine bones (p⁎) are also observed. H–J. Similar craniofacial defects are observed in Ednraﬂ/ﬂ;
Wnt1-Cre embryos. In some mutant embryos, the lower incisors are malformed and fused at their basis (i⁎ in I), a phenomenon not observed in Ednra−/− embryos. K–M. In some
Ednraﬂ/ﬂ;Wnt1-Cre embryos, a severe lower jaw phenotype is present, characterized by a cleft lower jaw (K, L). The angle of photography in L makes it appear that the jugal bone in L
projects more distally than the incisors, though this is not actually the case. The two black arrows in K indicate a gap between the palatine bones, resulting in a cleft palate. N–P.
Defects are not observed in Ednraﬂ/ﬂ; Hand2-Cre embryos. as, alisphenoid; bo, basioccipital; bs, basisphenoid; eo, exoccipital; et, ethamoid; f, frontal; h, hyoid; hb, hypobranchials; i,
incisor; in, incus; ip, interparietal; j, jugal; la, lacrimal; m, malleus; mx, maxilla; n; nasal; or, orbitosphenoid; p, palatine; pa, parietal; pe, petrosal; pm, premaxilla; ps, presphenoid;
ptr, pterygoid; s, stapes; so, supraoccipital; sq, squamosal/temporal; th, thyroid cartilage; ty, tympanic; v, vomer.
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Fig. 5. Aberrant bone development in E18.5 Ednra conditional knockout embryos. Ventral (A, C, E) and lateral (B, D, F) views of the skull and middle ear ossicles of control (Ednraﬂ/ﬂ)
(A, B), and Ednraﬂ/ﬂ;Wnt1-Cre (C–F) embryos. A, B. In Ednraﬂ/ﬂ embryos, normal middle ear structures are observed, including the malleus (m), incus (i) and stapes (s) and the
tympanic (ty) and gonial (g) bones. C, D. In some Ednraﬂ/ﬂ;Wnt1-Cre embryos, most middle ear structures are absent, though a few cartilaginous bodies are present (m⁎, abberant
malleus; i⁎, abberant incus). The hyoid (h) is also pulled ventro-rostrally and fused with the basisphenoid, matching the Ednra−/− phenotype. The stapes is also often attached to the
greater horns of the hyoid (hy) (black arrow in panel C). E, F. In most Ednraﬂ/ﬂ;Wnt1-Cre embryos, the malleus and incus are enlarged. The malleus is malformed and resembles an
articular. The incus is also malformed and often fused with an ectopic bone that also articulates with the pterygoid (pt). at, ala temporalis; at⁎, duplicated ala temporalis; lo, lamina
obturans; lo⁎, duplicated lamina obturans; p, palatine bone, pt⁎, duplicated pterygoid bone; sq, squamosal bone.
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remainder of the embryo; “C”) portions (red line #1 in Fig. 1E), with
DNA isolated from each half. Using PCR analysis designed to
speciﬁcally detect the recombined Ednra allele, recombination in
Ednraﬂ/ﬂ;Wnt1-Cre embryos was conﬁned to the rostral portion of the
embryo, while recombination in Ednraﬂ/ﬂ;Hand2-Cre embryos was
conﬁned to the caudal (C) segment (Fig. 1F). To further conﬁrm that
the recombination in E8.5 Ednraﬂ/ﬂ;Wnt1-Cre was occurring in cells
moving toward the ﬁrst arch, different Ednraﬂ/ﬂ;Wnt1-Cre embryos
were subdivided into rostral (all tissue above the ﬁrst arch) and caudal
(the remainder of the embryo) portions (red line #2 in Fig. 1E). In
these samples, recombinationwas nowobserved in the caudal portion
(Fig. 1F), conﬁrming that the Ednra conditional allele was inactivated
in these cells.
Since recombination of the Ednraﬂ gene was not observed in E8.5
Ednraﬂ/ﬂ;Hand2-Cre embryos, we examined recombination within
mandibular arch DNA in both E9.5 and E10.5 Ednraﬂ/ﬂ;Wnt1-Cre and
Ednraﬂ/ﬂ;Hand2-Cre embryos. Recombination was observed in
embryos that contained at least one Ednra fl allele and the Wnt1-
Cre transgene (Fig. 2A, lanes 5–8). Recombination was not detected
when using mandibular arch DNA extracted from embryos carrying
either the Ednraﬂ allele or the Wnt1-Cre transgene alone (Fig. 2A,
lanes 2–4). Further, no recombination was observed in yolk sac DNA
from Ednraﬂ/ﬂ;Wnt1-Cre embryos (Fig. 2A, lane 9), a site where theFig. 6. Gene expression analysis in Ednra conditional knockout embryos. Ventral view of E9.5
Wnt1-Cre (I–L, U–X) embryos following whole mount in situ hybridization analysis of Dlx5 (
expression. The heart has been removed to aid in visualization of the pharyngeal arches. A–
normal in Ednraﬂ/ﬂ;Hand2-Cre embryos (E, H), but almost completely absent in Ednraﬂ/ﬂ;Wnt
four transcription factors show normal expression in Ednraﬂ/ﬂ;Hand2-Cre embryos (Q, P), but
arch; 2, pharyngeal arch 2.transgene is not expressed. Recombination of the conditional Ednra
allele within mandibular arch DNA of Ednraﬂ/ﬂ;Hand2-Cre embryos
was also detectable at E9.5 and E10.5 (Fig. 2B, lanes 5–8). As
observed in Ednraﬂ/ﬂ;Wnt1-Cre embryos, Ednraﬂ gene recombination
was not observed in either Hand2-Cre or Ednraﬂ/ﬂ embryos (Fig. 2B,
lanes 2–4). Recombination was also not observed in yolk sac DNA of
Ednraﬂ/ﬂ;Hand2-Cre embryos (Fig. 2B, lane 9). Due to the speciﬁc Cre
strains used in this study, the Ednra ﬂox allele was not recombined
in the pharyngeal arch ectodermal, pouch endodermal and core
paraxial mesodermal cells. This accounts for the continued presence
of the ﬂox Ednra allele band in our PCR assays.
To further verify recombination in vivo, we performed in situ
hybridization analysis using an Ednra riboprobe that speciﬁcally
detected the region of the Ednra mRNA deleted following conditional
gene recombination of the Ednra allele (Kedzierski et al., 2003). In
E10.5 control embryos, expression of Ednra was observed throughout
the mandibular and second arches, with expression highest distally
and caudally (Fig. 2C). In E10.5 Ednraﬂ/ﬂ;Wnt1-Cre embryos, Ednra
expression was absent from the mandibular and second pharyngeal
arches (Fig 2D), consistent with pattern of gene recombination
obtained when using the Wnt1-Cre strain (Chai et al., 2000). In
contrast, arch Ednra expression in Ednraﬂ/ﬂ;Hand2-Cre embryos was
only absent in distal half of the ﬁrst and second arches (Fig. 2E),
consistent with pattern of gene recombination observed when using(A–L) and E10.5 (M–X) control (A–D, M–P), Ednraﬂ/ﬂ;Hand2-Cre (E–H, Q–T) and Ednraﬂ/ﬂ;
A, E, I, M, Q, U), Dlx6 (B, F, J, N, R, V), Hand2 (C, G, K, O, S, W) and Hand1 (D, H, L, P, T, X)
D. Gene expression in E9.5 control embryos. E–L. At E9.5, expression of all four genes is
1-Cre embryos (I, L). M–P. Gene expression in E10.5 control embryos. Q–X. At E10.5, all
are again almost completely absent in Ednraﬂ/ﬂ;Wnt1-Cre embryos (U–X). 1, mandibular
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Fig. 7. Affect of temporal antagonist treatment on facial development. Incidence of defects per litter was analyzed for each enumerated structure and treatment modality. The error
bars represent the standard deviation (see Materials and methods for a detailed description of data analysis). (A) Analysis of the incidence of defects in structures derived from the
ﬁrst pharyngeal arch. (B) Incidence of defects in structures derived form the second, third and fourth pharyngeal arch.
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Ednra gene inactivation has occurred using both Cre strains and also
illustrates the spatial speciﬁcity of Ednra gene inactivationwhen using
both Cre strains.
Craniofacial defects in E18.5 Ednraﬂ/ﬂ;Wnt1-Cre embryos
To determine the effect of Ednra gene recombination in Ednraﬂ/ﬂ;
Wnt1-Cre andEdnraﬂ/ﬂ;Hand2-Creembryos,weperformedgross analysis
of near-term embryos. E18.5 Ednraﬂ/ﬂ;Wnt1-Cre embryos had defects
similar to those observed in Ednra−/− embryos (Figs. 3D–F), including a
shortened lower jaw (Fig. 3G) that containedmystacial vibrissae (yellow
arrows in Fig. 3H) and a midline mandibular cleft (Fig. 3H). Analysis of
sagittal sections stained with hematoxylin and eosin further illustrated
tongue hypoplasia (Fig. 3I) and the presence of rugae, raised epithelial
ridges normally conﬁned to the palate of the mouth, on the ﬂoor of the
mouth (Fig. 3I). Lower incisors were present but primarily set in
mesenchyme (Fig. 3I). In addition, 24% (8/33) of Ednraﬂ/ﬂ;Wnt1-Cre
embryos had a more severe phenotype, in which the two mandibular
arch halves appeared as large ﬂaps of soft tissue that failed to fuse (Figs.
3J–L). This more severe phenotype correlated with speciﬁc Wnt1-Cre
animals, suggesting the presence or absence of modiﬁer alleles in these
complex genetic crosses. In contrast, the lower jaw of E18.5 Ednraﬂ/ﬂ;
Hand2-Cre embryos appeared normal (Figs. 3M–O). Since Hand2
daughter cells are found throughout the lower jaw of near-term
mouse embryos (Ruest et al., 2003) and most ventral cartilages areFig. 8. Analysis of craniofacial skeleton in E18.5 embryos. Lateral view of the skull (A, E, M, Q,
(C, G, K, O, S, W, a and e) views of the mandible bone and lateral view of middle ear structure
(A–D) or the antagonist at the listed time points (E–f). Antagonist treatment as early as E8
structures. The mandible becomes shortened, with loss of the coronoid (cr) process. In emb
zygomatic arch is observed in place of the coronoid process (black arrows in panels S, W and
incisors are present at all treatment regimens. In the middle ear, an ectopic bone strut (eb) is
(i) become increasingly dysmorphic, with treatment at E8.5/E9.0 resulting in almost comple
Meckel's cartilage; s, stapes; s⁎, malformed stapes; ty, tympanic ring bone.absent in the hand2 zebraﬁshmutant hands off (Miller et al., 2003; Yelon
et al., 2000), we believe that an absence of a phenotype in Ednraﬂ/ﬂ;
Hand2-Cre embryos reﬂects inactivation of the Ednra gene after Ednra
signaling has accomplished its required function.
To examine skeletal structure in the lower jaw inmore detail, E18.5
Ednraﬂ/ﬂ;Wnt1-Cre embryos were stained with alizarin red/alcian blue
to examine bone and cartilage, respectively. As observed in Ednra−/−
embryos (Figs. 4E–G), themandible in Ednraﬂ/ﬂ;Wnt1-Cre embryoswas
shortened and ﬂattened (Fig. 4H). On ventral view, the mandible in
these embryos resembled a small maxilla (Fig. 4I). The mandible
attached to the jugal bone of the zygomatic arch via a bone that
appeared to be a duplicated jugal bone (Figs. 4I, J). Duplications of the
palatine, pterygoid and lamina obturans bones and the ala temporalis
cartilage were also present (Figs. 4I, J and data not shown). Most of
Meckel's cartilage was also missing, though the symphysis was
present, surrounded by a small amount of membranous bone (data
not shown). As described above, the incisors were set in mesenchyme
rather than bone. In Ednraﬂ/ﬂ;Wnt1-Cre embryos with the more severe
phenotype (Figs. 4K–M), the two pieces of tissue that extended down
from themaxillawere composed almost completely of soft tissue, with
each containing an incisor (Figs. 4L, M). In 5/6 stained skulls examined,
incisor polarity was changed, with each incisor projecting downwards
(Fig. 4K). In contrast to these changes, defects were not observed in the
lower jaw structure of E18.5 Ednraﬂ/ﬂ;Hand2-Cre (Figs. 4N–P).
Because incomplete gene inactivation resulting in mosaicism is a
common problem with conditional mouse knockouts (Kwan, 2002;U, Y and c), ventral (B, F, J, N, R, V, Z and d), intra-lateral (top) and contra-lateral (bottom)
s (D, H, L, P, T, X, b and f) of embryos from females treated with either water at E8.5/E9.0
.5/E9.0 begins to cause changes in the structure of the mandible bone and middle ear
ryo treated between E8.5/E9.0 and E9.0/E9.5, a bone resembling the jugal bone of the
a). While shortened, the mandible bone retains an obvious mandibular structure. Lower
obvious following treatment between E8.0/E8.5 to E9.0/E9.5. The malleus (m) and incus
te loss of both elements. an, angular process; cd, condylar process; g, gonial bone; mc,
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Ednraﬂ/−;Wnt1-Cre embryos. In these embryos, one Ednra allele
contains the conditional mutation (ﬂ) and one contains the conven-
tional mutation (null, here referred to as “−”). In these embryos,
changes in jaw structure were identical to that of Ednraﬂ/ﬂ;Wnt1-Cre
embryos (Supplementary Figs. 2A–C), indicating that the extent of
gene recombination was similar between Ednraﬂ/ﬂ and Ednraﬂ/−
embryos. Similarly, defects were also not observed in E18.5 Ednraﬂ/−;
Hand2-Cre embryos (data not shown), indicating that the absence of a
phenotype was not due to insufﬁcient gene inactivation. We
conﬁrmed this hypothesis by breeding the Hand2-Cre line with the
Smoothened conditional knockout line to generate Smoﬂ/ﬂ;Hand2-Cre
embryos. In these embryos, severe mandibular defects similar to those
observed in Smoﬂ/ﬂ;Wnt1-Cre embryos were observed (data not
shown), illustrating that the Hand2-Cre line is capable of inactivating
conditional alleles. It is important to note that while the absence of a
phenotype in Ednraﬂ/ﬂ;Hand2-Cre and Ednraﬂ/−;Hand2-Cre embryos
could reﬂect an absence of Ednra, Edn1 or Ece1 in the arch
environment, numerous studies have shown that Ednra, Edn1 and
Ece1 are all expressed within the arch environment through at least
E11.5 (Clouthier et al., 1998; Fukuhara et al., 2004; Kurihara et al.,
1994; Maemura et al., 1996; Ozeki et al., 2004; Yanagisawa et al.,
1998a,b). We therefore believe that our ﬁndings reﬂect a temporal
requirement for Ednra signaling rather than reﬂect a limited window
of endothelin family member expression in the arch.
Differential changes in middle ear ossicles in Ednraﬂ/ﬂ;Wnt1-Cre embryos
Defects were also present in middle ear structures of Ednraﬂ/ﬂ;
Wnt1-Cre embryos, though the extent of malformation was more
variable. In Ednra−/− embryos, themalleus and incus are not detectable,
though small nodules of undeﬁned cartilage are present (Clouthier et
al., 1998). By gross analysis, identical changes were observed in 25%
(12/48) of mallei from E18.5 Ednraﬂ/ﬂ;Wnt1-Cre embryos (Figs. 5C, D).
In contrast, 75% of mallei examined from Ednraﬂ/ﬂ;Wnt1-Cre embryos
were enlarged in one or both sides of the skull (Figs. 5E, F), suggesting a
threshold affect of Ednra signaling on malleus development. We
randomly chose 14 of these enlarged mallei for measurement using
Metamorph imaging software. We also measured 8 mallei from wild
type embryos and 7 mallei from Ednraﬂ/ﬂ;Wnt1-Cre embryos in which
the mallei resembled that of Ednra−/− embryos. Of the enlarged mallei,
we found that 8/14 were similar in length (641.09 μm (±49. 9 μm) to
that of wild type embryos (676.68 μm (±62. 4 μm), while 6/14 mallei
were longer (1082.04 μm (±194. 3 μm) than wild type embryos. In
addition, 12/14 of these mallei were wider (558.57 μm (±150. 6 μm)
than wild type mallei (313.30 μm (±20.54 μm). The incus in Ednraﬂ/ﬂ;
Wnt1-Cre embryos was also malformed, contained several processes
and often articulatedwith the pterygoid in the skull base via an ectopic
bone (Figs. 5E, F). This bonewas present in at least one side of the skull
base in 14/24 Ednraﬂ/ﬂ;Wnt1-Cre embryos examined, with the severity
of the lower jaw phenotype not impacting the presence or absence of
the ectopic bone (data not shown). It should be noted that the incus
defects are more severe than those observed for the palatoquadrate in
suc/et1mutant zebraﬁsh, likely reﬂecting the impact of the loss of the
malleus on incus shape in mouse embryos (Clouthier et al., 2003). The
stapes of Ednraﬂ/ﬂ;Wnt1-Cre embryos appeared normal, though the
stapes on at least one side of the skull was attached to the greater horn
of the hyoid in 16/24 Ednraﬂ/ﬂ;Wnt1-Cre embryos examined (Fig. 5C), a
defect observed at the same frequency in Ednra−/− embryos (data notFig. 9.Whole mount in situ hybridization analysis following antagonist treatment. Lateral (D
treated (F–n) embryos hybridized with DIG-labeled cRNA riboprobes against Dlx3 (A, F, K, P, U
S, X, c, h and m) and Hand1 (E, J, O, T, Y, d, i and n). Each of the genes examined shows a distin
the ﬁrst arch after antagonist treatment at E8.0/E8.5, with loss in the second arch appearin
expression of both Dlx5 and Dlx6 is more evident at E8.5 than at E8.0/E8.5, reﬂecting the diff
show a narrower temporal sensitivity to antagonist treatment, with disrupted expression pshown). This would be considered an intermediate pharyngeal arch
phenotype,where themost distal derivative of the second arch fuses to
the most proximal derivative.
Mandibular arch gene expression in Ednraﬂ/ﬂ;Wnt1-Cre embryos
Targeted inactivation of either Edn1 or Ednra in the mouse disrupts
expression of multiple genes in the pharyngeal arches (Clouthier et al.,
1998, 2000; Fukuhara et al., 2004; Kitano et al., 1998; Ozeki et al.,
2004; Ruest et al., 2004). To examinewhether similar gene expression
patterns were disrupted in conditional knockout embryos, we
performed whole mount in situ hybridization analysis on E9.5 and
E10.5 embryos, focusing on gene expression changes within the
mandibular arch. Expression of Dlx5, Dlx6, Hand2 and Hand1 was
similar between E9.5 wild type (Figs. 6A–D) and Ednraﬂ/ﬂ;Hand2-Cre
(Figs. 6E–H) embryos, while expression of all four genes was disrupted
in E9.5 Ednraﬂ/ﬂ;Wnt1-Cre embryos (Figs. 6I–L). Like at E9.5, gene
expression was similar between E10.5 wild type (Figs. 6M, N) and
Ednraﬂ/ﬂ;Hand2-Cre embryos (Figs. 6Q–T), while expression of all four
genes was almost completely absent in E10.5 Ednraﬂ/ﬂ;Wnt1-Cre
embryos (Figs. 6U–X). Loss of expression in Ednraﬂ/ﬂ;Wnt1-Cre
embryos but not in Ednraﬂ/ﬂ;Hand2-Cre embryos argues that Ednra
signaling is required for initiation but not maintenance of genes
involved in lower jaw development.
Craniofacial defects in wild type embryos following Ednra antagonism
in utero
To better deﬁne the exact timing of Ednra action, we took a second
approach, in which Ednra signaling was blocked for short periods
during development using an Ednra-speciﬁc antagonist (Padilla et al.,
2006; Sprogar et al., 2007). The antagonist, TBC3214 (Encysive
Pharmaceuticals), is an orally-bioavailable non-peptidic antagonist
with a sub-nanomolar IC50 (Wu et al., 2001). Because of this and its
short half life (∼4 h), it is an ideal compound bywhich to elucidate the
timing of Ednra function in vivo.Wild type pregnant femalemicewere
given the antagonist by gavage between E8.0 and E10.0, a time period
covering both migration of cranial NCCs to the arches, and their
subsequent patterning, proliferation and initial differentiation. The
antagonist was given at either one time point or two time points
separated by 12 h. This latter dosing was performed to ensure that
with the short half-life of the antagonist, adequate receptor blocking
was achieved.
While Ednra signaling likely acts through IP3 intracellular
signaling pathway (Ivey et al., 2003; Dettlaff-Swierez et al, 2005;
Walker et al., 2007) that can be difﬁcult to measure in vivo, we
examined both bone and cartilage formation and gene expression to
conﬁrm receptor blockade and to determine the crucial timing of
Ednra action. To ﬁrst examine the affect of Ednra blockade on overall
facial development, embryos from treated females were collected at
E18.5 and stained with alizarin red and alcian blue. Skeletal structures
derived from the pharyngeal arches were then scored for defects, with
any deviation from normal structure scored as a defect. Antagonist
treatment at E8.0 resulted in minor changes in about 10% of embryos,
with defects conﬁned to the gonial, pterygoid and squamosal bones
(Figs. 7A, 8E–H, Supplementary Fig. 3C, D. Supplementary Table 1).
The changes in the pterygoid and gonial coincided with the presence
of an ectopic bone in the skull base (Supplementary Table 1); this
structure was similar to the one observed in the Ednraﬂ/ﬂ;Wnt1-Crelx3, Dlx5 and Dlx6) and ventral (Hand2 and Hand1) views of control (A–E) and TBC3214-
, Z, e and j), Dlx5 (B, G, L, Q, V, a, f and k) and Dlx6 (C, H, M, R, W, b, g and l), Hand2 (D, I, N,
ct sensitivity to antagonist treatment. All three Dlx genes ﬁrst show loss of expression in
g after treatment at E9.0/E9.5. By E9.5, expression is fully restored. Note that disrupted
erences observed in skeletal defects at these time periods. Hand2 and Hand1 expression
rimarily observed between E8.5 and E9.0.
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defects in all ﬁrst arch-derived structures (Figs. 7A, 8I–L and
Supplementary Fig. 3E, F. Supplementary Table 1). These included
slight hypoplasia of many ﬁrst arch derivatives and the presence of the
ectopic bone (Fig. 8L). In addition, a duplication of the jugal bone was
present (Fig. 8K). Defects were also present in arch 2 derivatives (Fig.
7B), while defects were not observed arch 3 and 4 derivatives.
Treatment at E8.5 also resulted in defects similar to those observed
with antagonist treatment at E8.0/E8.5, though the overall incidence
was decreased alone (Figs. 7A, 8M–P, Supplementary Figs. 3G, H and
Supplementary Table 1). Defects were also observed at a low
incidence rate in arch 2, 3 and 4 derivatives (Fig. 7B).
Antagonist treatment at E8.5/E9.0, E9.0 and E9.0/9.5 all resulted in
severe defects in ﬁrst arch derivatives, with little variation observed in
the type or incidence of defect within or between groups. Defects
included signiﬁcant mandibular hypoplasia, duplication of the jugal
and alisphenoid bones, loss or severe malformation of the malleus,
loss of the tympanic ring bone andMeckel's cartilage and the presence
of the ectopic bones (Figs. 7A, 8Q–b and Supplementary Fig. 3I–P).
Defects in structures derived from the more caudal arches included
fusion of the hyoid bone to the pterygoid bones (following blockade at
E8.5/E9.0 and E9.0), similar to the fusion and disruption of normal
thyroid cartilage architecture (Fig. 7B and Supplementary Table 1). All
observed defects were consistent with those observed in Ednra−/− and
Ednraﬂ/ﬂ;Wnt1-Cre embryos. One notable exception was the mandible,
which while hypoplastic, never showed a complete transformation to
a maxilla-like structure (as described above, a duplication of the jugal
bone was observed).
In contrast to the changes observed with treatment between E8.5
and E9.0, treatment at E9.5 alone resulted in very few changes (Figs.
7A, B, 8c–f, Supplementary Figs. 3O, P), through the ectopic bone was
still present in 10% of embryos (Supplementary Table 1). In addition,
defects in arches 3 and 4 were still present at a low level
(Supplementary Table 1). The only defects observed following
treatment at E9.5/10.0 were defects in the gonial, pterygoid and the
presence of the ectopic bone (possibly all due to presence of the
ectopic bone) (Supplementary Figs. 3Q, R), though these defects were
observed in up to 40% of embryos (Supplementary Table 1). Antagonist
treatment at E10.0 alone resulted in low incidence of defects, limited
to the pterygoid and ectopic bone (Supplementary Figs. 3S, T and
Supplementary Table 1).
Changes in gene expression following Ednra antagonism
To examine how these changes in jaw and middle ear structures
were reﬂected in changes at the molecular level, we examined the
expression pattern of ﬁve genes whose expression is disrupted in
Ednra−/− and Edn1−/− embryos. Antagonist treatment at E8.0 did not
result in consistent changes in gene expression in Dlx3, Dlx5, Dlx6
and Hand2, though the Hand1 expression domain was shifted
distally (Figs. 9A–E). After treatment at E8.0/E8.5, the expression of
Dlx3 was weaker in the ﬁrst arch; Hand1 expression was again
shifted distally in the mandibular arch, with Dlx6 unchanged (Figs.
9K–O). Following antagonist treatment at E8.5 alone, only Dlx3
showed a clear change in the ﬁrst arch (yellow arrow in Fig. 9P).
However, following treatment at E8.5/E9.0 (Figs. 9U–Y) or E9.0
alone (Figs. 9Z–d), mandibular arch expression of all ﬁve genes was
changed to some extent, with Dlx3 being virtually absent in the
ﬁrst arch at both time points (Figs. 9U, Z). Interestingly, Hand1
(Figs. 9Y, d) and Hand2 (Figs. 9X, c) expression along the rostral
mandibular arch was never lost, which may explain the absence of
distal mandibular defects. Antagonist treatment at E9.0/E9.5
resulted in disrupted expression of Dlx3, Dlx5 and Dlx6 in the
ﬁrst and second arches, Hand1 and Hand2 less severely affected
(Figs. 9e–i). The expression of all ﬁve genes in arches one and two
appeared unaffected by antagonist treatment at E9.5 (Figs. 9j–n).Together, these results illustrate that blocking Ednra signaling at
discrete time periods affects the development of particular
craniofacial structures by disrupting speciﬁc temporal signaling
networks responsible for rostral–caudal patterning of the phar-
yngeal arches.
Discussion
Herewe have shown that Ednra signaling is crucial for early cranial
NCC development. Using conditional inactivation of the Ednra gene in
cranial NCCs at both E8.5 and E9.5, we found that only inactivation at
E8.5 resulted in craniofacial defects, with these defects resembling
those of Ednra−/− embryos (Clouthier et al., 1998; Ruest et al., 2004).
Inactivation of Ednra at E9.5 did not disrupt normal jaw development.
We further reﬁned this timing by blocking Ednra signaling in pregnant
wild type female mice to show that Ednra signaling is required
between E8.25 and E9.0. Again, blocking receptor activity after E9.0
resulted in very few changes in skull structure. In both cases, an
ectopic bone formed between the gonial bone and pterygoid bone.
These ﬁndings support a model in which Ednra signaling is required
for both early establishment of a proximal distal patterning program
and induction of a gene expression proﬁle necessary to execute this
program. Further, we propose that increasing Ednra signaling levels in
the mandibular arch may have contributed to the evolution of the
vertebrate middle ear.
Timing and function of Ednra signaling
In this current study, we have shown that Ednra signaling is ﬁrst
required by NCCs between E8.0 and E8.5, with this requirement
continuing between E9.0 and E9.5. This time period is earlier than
previously described using short term in vitro culture in the presence
of another Ednra antagonist (Fukuhara et al., 2004), with the
difference likely reﬂecting the potency of the antagonist for its
receptor (IC50: 40 pM) and increased sensitivity of using an orally
bioavailable antagonist coupled with analysis of embryos at E18.5.
Initial Ednra activity between E8.0 and E8.5 could suggest that Ednra
signaling is either required for NCC movement/targeting within the
arches to speciﬁc arch sub-domains or required for immediate
patterning of post-migratory NCCs. Recent evidence would favor the
latter explanation. Ednra signaling is not required for mouse cranial
NCCs to reach the pharyngeal arches (Abe et al., 2007; Clouthier et al.,
2003), even though Ednra expression is observed in migrating NCCs
by E8.25 (Sato et al., 2008) and is not required by NCC-derived cells in
the arches after E10.5 (Ruest et al., 2005). Similarly, Ednra1;Ednra2
double morphant zebraﬁsh embryos also do not have defects in NCC
migration (Nair et al., 2007). In addition, crude injection of human
EDN1 into the mandibular arch of suc;edn1−/− zebraﬁsh after most
migration is complete leads to a rescue of the suc;edn1−/− phenotype
(Miller et al., 2000). Together, these ﬁndings have led to the hypothesis
that Ednra signaling establishes or maintains patterning along the
arch dorsal–ventral axis (Nair et al., 2007). If this hypothesis is correct,
our current ﬁndings indicate that this patterning process is initiated
very early in arch development, likely immediately before or after
NCCs reach their destination. We cannot determine whether the early
sensitivity to Ednra blockade (the E8.0/E8.5 window) represents a
speciﬁc developmental event, since receptor blockade at E8.0/E8.5
produces defects always observed at later receptor blockade time
points.
It is plausible that, like in the zebraﬁsh, early signaling establishes
the D-V pattern and that later Ednra signaling reinforces this
developmental program (Nair et al., 2007). However, directly asses-
sing the similarity in temporal signaling betweenmouse and zebraﬁsh
is difﬁcult due to the presence of two ednra genes in zebraﬁsh, one of
which is found in the arch ectoderm and may positively regulate edn1
expression (Nair et al., 2007). In the mouse, there is only one known
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derived mesenchyme (Clouthier et al., 1998; Yanagisawa et al., 1998a;
Yanagisawa, 1994). Our present ﬁnding that the phenotype of E18.5
Ednraﬂ/ﬂ;Wnt1-Cre embryos is identical to that of E18.5 Ednra−/−
embryos conﬁrms this fact.
Several aspects of arch development that appear to be shared
between both mouse and zebraﬁsh are that Ednra-speciﬁc D-V
patterning along the arch axis occurs over a rather long period
(∼18 h in the mouse) and that disrupting Ednra signaling at any point
during this time disrupts lower jaw development. Further, an
exquisite sensitivity to the level of Ednra signaling exists in NCCs. In
Ednra1 morphant zebraﬁsh embryos, distal lower jaw development is
normal while the intermediate domain is disrupted (Nair et al., 2007).
In Ednra1;Ednra2 double morphants, both distal and intermediate
domains are disrupted. Thus, the overall level of Ednra signaling is
crucial in directing different aspects of mandibular arch patterning.
This view is supported by our current ﬁnding that while most defects
observed in Ednra−/− embryos are observed following Ednra antagon-
ism between E8.5 and E9.0, complete homeotic transformation of the
mandible into a maxilla is not observed following any of the one- or
two-dose antagonist treatment regimens. This indicates that the
length of antagonist administration was not sufﬁcient to produce this
speciﬁc homeotic event and further highlights that the speciﬁcation of
NCCs towards a speciﬁc skeletal lineage is a broad developmental
event requiring changes in the expression of numerous genes over an
extended development window.
A second hypothesis for Ednra action has been proposed in which
Ednra signaling regulates segregation of NCCs to the distal mandibular
arch (Walker et al., 2006). In suc;edn1−/− embryos, themandibular arch
does not appear to properly elongate, though this defect is not present
in older mutant embryos. This outgrowth defect has led to the
proposal that absence of Edn1 leads to an initial failure of arch
elongation (Walker et al., 2006, 2007). Inhibiting elongation would
disrupt a proposed Edn1 gradient within the mandibular arch that is
hypothesized to contribute to D-V patterning (Kimmel et al., 2003,
2007). These changes would subsequently result in a failure to
segregate and pattern intermediate and ventral populations of NCCs
within the arch. While we cannot rule out a role for Ednra signaling in
mandibular arch outgrowth in the mouse, delayed elongation of this
arch is not readily apparent (data not shown). Further, a role for Ednra
signaling in NCC segregationwould have to be restricted to a subset of
NCCs within the mandibular arch. In Ednra−/− embryos, global changes
in gene expression within the intermediate and distal regions of the
pharyngeal arches are not observed (Clouthier et al., 1998, 2000; Ruest
et al., 2004). While it is possible that D-V patterning in themandibular
arch of mice and zebraﬁsh occurs through different mechanisms, we
would propose that NCCs of different midbrain/hindbrain regions
have differential requirements for Ednra signaling. Chimera analysis in
mice has shown that all ﬁrst arch structures that have a cell
autonomous requirement for Ednra signaling contain a midbrain
NCC contribution (Clouthier et al., 2003), based on homology with
chick NCC fate maps (Kontges and Lumsden, 1996). Perhaps it is these
cells in the ﬁrst arch that are most sensitive to Ednra signaling for D-V
patterning and/or segregation. Conditional inactivation of the Ednra
gene in a hindbrain or rhombomere-speciﬁc manner will be required
to address this question.
Changes in malleus shape and the importance of endothelin signaling
Varying Edn1 levels are believed to play a role in the shape and size
of second arch elements in zebraﬁsh, possibly reﬂecting a gradient of
Edn1 within the arch. These elements, the opercle and branchiostegal
rays, are part of the gill breathing apparatus. Following partial
downregulation of edn1 using edn1 morpholinos, an increase in the
size of the opercle was observed (referred to as the opercle-gain
phenotype (Kimmel et al., 2003). The opercle-gain phenotype ishypothesized to reﬂect a change in an Edn1 gradient within the arch,
leading to expansion of the future opercle (Kimmel et al., 2003). Here
we have shown that the malleus, a ﬁrst arch derivative, is larger than
normal in 75% of in Ednraﬂ/ﬂ;Wnt1-Cre embryos. While many aspects
of vertebrate auditory system evolution are controversial, it is clear
that changes in ossicle size have occurred throughout evolution,
resulting in varying frequency reception (Allin, 1975). It is tempting to
speculate that increasing Ednra signaling during mammalian evolu-
tion (through expansion of an Edn1 gradient or other mechanisms are
not well understood) has been key to the development of multiple
structures within the pharyngeal arches, including the gill apparatus
and middle ear. To address this possibility, it will be important to
determine if the appearance of the endothelin gene in the vertebrate
lineage corresponds to anatomical changes within the middle ear.
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